A Scalable Nutrition Adherence Intervention
Key claim: Investigators hypothesize that a scalable adherence program will achieve high adherence to Mediterranean and modified Mediterranean-ketogenic diets and that these diets will improve gut–brain axis markers of Alzheimer’s pathogenesis more in adults with mild cognitive impairment than in cognitively normal older adults.
Abstract
Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida.
The investigators hypothesize that:
1. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in the Modified Mediterranean-Ketogenic diet (MMKD) group and an average score of >6 on the MEDAS questionnaire in the Mediterranean group during the 10-week program. Further, we hypothesize that the use of ongoing monthly support groups will bolster long-term adherence.
Objective 2: To evaluate the effects of adherence to Mediterranean versus MMKD on novel gut-brain axis markers of Alzheimer’s disease pathogenesis in individuals with mild cognitive impairment compared to cognitively normal older adults.
The investigators hypothesize that individuals with mild cognitive impairment will:
- Have greater evidence of gut dysbiosis at baseline than cognitively normal controls and
- Will demonstrate greater increases in beneficial gut microbial metabolites in response to adherence to Mediterranean-Ketogenic nutrition and the Mediterranean diet compared to CN controls.
Why this matters
Investigators hypothesize that a scalable adherence program will achieve high adherence to Mediterranean and modified Mediterranean-ketogenic diets and that these diets will improve gut–brain axis markers of Alzheimer’s pathogenesis more in adults with mild cognitive impairment than in cognitively normal older adults.